5:@0.890196:0.957873:0.898787:0.957873:0.898787:0.938882:0.890196:0.938882:0.008591
1:@0.941813:0.186378:0.963291:0.186378:0.963291:0.138900:0.941813:0.138900:0.021478
introduction:@0.794874:0.064721:0.882352:0.064721:0.882352:0.047603:0.794874:0.047603:0.003511:0.008759:0.006387:0.008311:0.008442:0.008423:0.008367:0.008178:0.006387:0.003511:0.008442:0.008759
depending on the tumor type . Genes affected by the driver mutations are called cancer :@0.147059:0.121273:0.886427:0.121273:0.886427:0.100900:0.147059:0.100900:0.011322:0.009131:0.011505:0.009039:0.011596:0.011391:0.005615:0.011459:0.009861:0.004109:0.010845:0.011756:0.004109:0.006620:0.011299:0.009039:0.004109:0.006163:0.011413:0.017485:0.010843:0.007807:0.004109:0.006437:0.009724:0.011502:0.009039:0.012178:0.004497:0.004109:0.015817:0.009039:0.011598:0.009039:0.007670:0.004109:0.009085:0.005969:0.005787:0.009108:0.009108:0.006209:0.009108:0.011391:0.004109:0.010843:0.009724:0.004109:0.006620:0.011299:0.009039:0.004109:0.011391:0.007807:0.005547:0.009633:0.009039:0.007807:0.004109:0.017280:0.011071:0.006551:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.004109:0.009085:0.007442:0.009039:0.004109:0.009108:0.009405:0.005385:0.005184:0.009106:0.011391:0.004109:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.004109
20:@0.394402:0.113657:0.406565:0.113657:0.406565:0.101780:0.394402:0.101780:0.006082:0.006082
driver genes and can be further divided into oncogenes and tumor suppressor genes. :@0.147059:0.141852:0.886418:0.141852:0.886418:0.121479:0.147059:0.121479:0.011391:0.007807:0.005547:0.009633:0.009039:0.007807:0.006483:0.009656:0.009039:0.011596:0.009039:0.007670:0.006483:0.009085:0.011596:0.011391:0.006483:0.009108:0.009085:0.011756:0.006483:0.011254:0.009039:0.006483:0.006366:0.011413:0.007967:0.006620:0.011299:0.009039:0.007807:0.006483:0.011391:0.005547:0.009838:0.005547:0.011322:0.009108:0.011391:0.006483:0.005615:0.011391:0.006209:0.011048:0.006483:0.010843:0.011596:0.008994:0.011048:0.009656:0.009039:0.011596:0.009039:0.007670:0.006483:0.009085:0.011598:0.011391:0.006483:0.006163:0.011413:0.017485:0.010843:0.007807:0.006483:0.007510:0.011071:0.011048:0.011071:0.007442:0.009039:0.007533:0.007875:0.010843:0.007807:0.006483:0.009656:0.009039:0.011596:0.009039:0.007670:0.004497:0.004109
Oncogenes acquire activating mutations that confer a positive selection advantage and :@0.147059:0.162431:0.886456:0.162431:0.886456:0.142058:0.147059:0.142058:0.016298:0.011596:0.008994:0.011048:0.009656:0.009039:0.011596:0.009039:0.007670:0.005433:0.009291:0.008994:0.010706:0.011413:0.005615:0.007442:0.009039:0.005433:0.009291:0.009108:0.006437:0.005547:0.009838:0.008811:0.006437:0.005615:0.011459:0.009861:0.005433:0.017280:0.011071:0.006551:0.008809:0.006437:0.005547:0.010843:0.011619:0.007670:0.005433:0.006620:0.011391:0.008811:0.006437:0.005433:0.008994:0.010843:0.011756:0.006026:0.009039:0.007807:0.005433:0.009291:0.005433:0.011505:0.010957:0.007601:0.005273:0.006437:0.005547:0.009633:0.009039:0.005433:0.007875:0.008948:0.005182:0.009108:0.009108:0.006437:0.005547:0.010843:0.011756:0.005473:0.009291:0.011322:0.009838:0.009085:0.011391:0.006551:0.009199:0.009656:0.009039:0.005433:0.009085:0.011596:0.011391:0.004109
act in a dominant way. Tumor suppressor genes drive cancer by inactivation or loss of :@0.147059:0.181833:0.886350:0.181833:0.886350:0.161460:0.147059:0.161460:0.009291:0.009108:0.006437:0.005661:0.005615:0.011756:0.005661:0.009291:0.005661:0.011322:0.010843:0.017645:0.005615:0.011687:0.009085:0.011391:0.006437:0.005661:0.014723:0.008925:0.007989:0.004497:0.005661:0.010911:0.011413:0.017485:0.010843:0.007807:0.005661:0.007512:0.011069:0.011048:0.011071:0.007444:0.009039:0.007531:0.007875:0.010843:0.007807:0.005661:0.009656:0.009039:0.011596:0.009039:0.007670:0.005661:0.011391:0.007807:0.005545:0.009635:0.009039:0.005661:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.005661:0.010843:0.009724:0.005661:0.005615:0.011687:0.009291:0.009108:0.006437:0.005547:0.009838:0.008811:0.006437:0.005547:0.010843:0.011756:0.005661:0.010843:0.007807:0.005661:0.005182:0.010957:0.007533:0.007670:0.005661:0.010843:0.006209:0.004109
activity often through bi-allelic mutations, which is the case for most familial cancers:@0.147059:0.201236:0.850920:0.201236:0.850920:0.180863:0.147059:0.180863:0.009291:0.009108:0.006437:0.005547:0.009838:0.005273:0.006437:0.009724:0.003675:0.010843:0.006197:0.005969:0.009039:0.011756:0.003675:0.006620:0.011459:0.007442:0.010820:0.011413:0.009930:0.011459:0.003675:0.010820:0.005615:0.007533:0.009405:0.005387:0.005182:0.008948:0.005250:0.005547:0.008994:0.003675:0.017280:0.011069:0.006551:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.004497:0.003675:0.014792:0.011459:0.005547:0.008765:0.011459:0.003675:0.005615:0.007670:0.003675:0.006620:0.011299:0.009039:0.003675:0.009108:0.009291:0.007873:0.009039:0.003675:0.006026:0.010843:0.007807:0.003675:0.017488:0.010957:0.007510:0.006437:0.003675:0.006209:0.009085:0.017645:0.005752:0.005250:0.005798:0.009405:0.005250:0.003675:0.009108:0.009085:0.011596:0.008994:0.009039:0.007624:0.007670
20,21:@0.850908:0.193620:0.877857:0.193620:0.877857:0.181743:0.850908:0.181743:0.006082:0.006082:0.002622:0.006082:0.006082
. :@0.877856:0.201236:0.886461:0.201236:0.886461:0.180863:0.877856:0.180863:0.004497:0.004109
An example of a cancer driver gene is TP53. This gene encodes for the p53 protein, :@0.147059:0.220639:0.886345:0.220639:0.886345:0.200266:0.147059:0.200266:0.014929:0.011756:0.007076:0.009108:0.010089:0.009085:0.017280:0.011162:0.005182:0.009039:0.007076:0.010840:0.006209:0.007076:0.009291:0.007076:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.007076:0.011391:0.007807:0.005547:0.009633:0.009039:0.007807:0.007076:0.009656:0.009039:0.011596:0.009039:0.007076:0.005615:0.007670:0.007076:0.013354:0.012167:0.010432:0.010432:0.004497:0.007076:0.011470:0.011470:0.005615:0.007670:0.007076:0.009656:0.009039:0.011596:0.009039:0.007076:0.009039:0.011596:0.008994:0.011274:0.011322:0.009039:0.007670:0.007076:0.006026:0.010843:0.007807:0.007076:0.006620:0.011299:0.009039:0.007076:0.011276:0.010432:0.010432:0.007076:0.011071:0.007442:0.010820:0.006209:0.009039:0.005615:0.011756:0.004497:0.004109
which monitors genomic integrity in the cell cycle and forces genetically damaged :@0.147059:0.240042:0.886418:0.240042:0.886418:0.219669:0.147059:0.219669:0.014792:0.011459:0.005547:0.008765:0.011459:0.008743:0.017485:0.010843:0.011756:0.005273:0.006209:0.010843:0.007624:0.007670:0.008743:0.009656:0.009039:0.011598:0.010840:0.017645:0.005547:0.008994:0.008743:0.005615:0.011391:0.006209:0.009039:0.009861:0.007807:0.005273:0.006437:0.009724:0.008743:0.005615:0.011756:0.008743:0.006620:0.011299:0.009039:0.008743:0.008994:0.008948:0.005387:0.005250:0.008743:0.009382:0.009519:0.008765:0.005182:0.009039:0.008743:0.009085:0.011596:0.011391:0.008743:0.006026:0.010843:0.007442:0.008994:0.009039:0.007670:0.008743:0.009656:0.009039:0.011596:0.009131:0.006437:0.005547:0.009108:0.009405:0.005387:0.005182:0.009724:0.008743:0.011573:0.009085:0.017577:0.009199:0.009656:0.009108:0.011391:0.004109
cells into senescence or apoptosis, hence its common moniker: “the guardian of the :@0.147059:0.259445:0.886439:0.259445:0.886439:0.239072:0.147059:0.239072:0.008994:0.008948:0.005387:0.005250:0.007670:0.007533:0.005615:0.011391:0.006209:0.011048:0.007533:0.007873:0.009039:0.011598:0.009039:0.007873:0.008994:0.009039:0.011596:0.008994:0.009039:0.007533:0.010843:0.007807:0.007533:0.008811:0.011505:0.010820:0.011048:0.006209:0.010957:0.007601:0.005615:0.007670:0.004497:0.007533:0.011299:0.009039:0.011596:0.008994:0.009039:0.007533:0.005271:0.006437:0.007670:0.007533:0.008994:0.010843:0.017645:0.017485:0.010843:0.011756:0.007533:0.017485:0.010845:0.011756:0.005750:0.010272:0.009039:0.008126:0.004497:0.007533:0.006232:0.006620:0.011299:0.009039:0.007533:0.009861:0.011596:0.009085:0.007442:0.011391:0.005798:0.009085:0.011756:0.007533:0.010843:0.006209:0.007533:0.006620:0.011302:0.009039:0.004109
genome” . The BRAF kinase is also a known cancer driver, prevalent in melanoma and :@0.147059:0.278847:0.886481:0.278847:0.886481:0.258474:0.147059:0.258474:0.009656:0.009039:0.011596:0.010843:0.017485:0.007282:0.007647:0.012164:0.004497:0.004794:0.011470:0.011311:0.009039:0.004794:0.012461:0.013650:0.014929:0.011276:0.004794:0.010706:0.005615:0.011687:0.009291:0.007873:0.009039:0.004794:0.005615:0.007670:0.004794:0.009405:0.005250:0.007875:0.011048:0.004794:0.009291:0.004794:0.010706:0.011596:0.010866:0.014723:0.011756:0.004794:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.004794:0.011391:0.007807:0.005547:0.009633:0.009039:0.006255:0.004497:0.004794:0.011071:0.007442:0.009336:0.009838:0.009405:0.005182:0.009039:0.011391:0.006437:0.004794:0.005615:0.011756:0.004794:0.017485:0.008948:0.005433:0.009085:0.011596:0.010843:0.017577:0.009291:0.004794:0.009085:0.011598:0.011391:0.004109
22:@0.220607:0.271231:0.232771:0.271231:0.232771:0.259354:0.220607:0.259354:0.006082:0.006082
other cancer types . The constitutive activation of BRAF causes a dysregulation of the :@0.147059:0.298250:0.886486:0.298250:0.886486:0.277877:0.147059:0.277877:0.010820:0.006620:0.011299:0.009039:0.007807:0.005593:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.005593:0.006437:0.009724:0.011502:0.009039:0.007670:0.012161:0.004497:0.005593:0.011470:0.011311:0.009039:0.005593:0.008994:0.010845:0.011619:0.007510:0.006437:0.005273:0.006163:0.011071:0.006437:0.005547:0.009633:0.009039:0.005593:0.009291:0.009108:0.006437:0.005547:0.009838:0.008811:0.006437:0.005547:0.010843:0.011756:0.005593:0.010843:0.006209:0.005593:0.012463:0.013650:0.014929:0.011276:0.005593:0.009108:0.008811:0.011413:0.007875:0.009039:0.007670:0.005593:0.009291:0.005593:0.011324:0.009724:0.007604:0.007442:0.009039:0.009861:0.011550:0.005433:0.008811:0.006437:0.005547:0.010843:0.011756:0.005593:0.010843:0.006209:0.005593:0.006620:0.011299:0.009039:0.004109
20:@0.303829:0.290634:0.315993:0.290634:0.315993:0.278757:0.303829:0.278757:0.006082:0.006082
ERK-MAP signalling pathway, leading to increased cell proliferation and survival. The :@0.147059:0.317653:0.886462:0.317653:0.886462:0.297280:0.147059:0.297280:0.012098:0.013376:0.014541:0.007533:0.019608:0.014929:0.012167:0.005478:0.007601:0.005615:0.009861:0.011687:0.009405:0.005385:0.005250:0.005615:0.011459:0.009861:0.005478:0.011368:0.008811:0.006620:0.011071:0.014723:0.008925:0.007989:0.004497:0.005478:0.005182:0.009291:0.009291:0.011391:0.005615:0.011459:0.009861:0.005478:0.006209:0.011048:0.005478:0.005615:0.011596:0.008994:0.007442:0.009291:0.009291:0.007875:0.009108:0.011391:0.005478:0.008994:0.008948:0.005387:0.005250:0.005478:0.011071:0.007442:0.010934:0.005250:0.005615:0.006026:0.009039:0.007898:0.008811:0.006437:0.005547:0.010843:0.011756:0.005478:0.009085:0.011596:0.011391:0.005478:0.007510:0.011413:0.008400:0.009838:0.005547:0.009838:0.009405:0.004976:0.004497:0.005478:0.011470:0.011311:0.009039:0.004109
most common mutation in BRAF is the V600E substitution, although other mutations :@0.147059:0.337056:0.886416:0.337056:0.886416:0.316683:0.147059:0.316683:0.017485:0.010957:0.007510:0.006437:0.005090:0.008994:0.010843:0.017645:0.017485:0.010843:0.011756:0.005090:0.017280:0.011071:0.006551:0.008811:0.006437:0.005547:0.010843:0.011756:0.005090:0.005615:0.011756:0.005090:0.012463:0.013650:0.014929:0.011276:0.005090:0.005615:0.007670:0.005090:0.006617:0.011302:0.009039:0.005090:0.015089:0.010432:0.010432:0.010432:0.012098:0.005090:0.007510:0.011345:0.010934:0.007510:0.006437:0.005273:0.006163:0.011071:0.006437:0.005547:0.010843:0.011756:0.004497:0.005090:0.009405:0.004905:0.006622:0.011299:0.010820:0.011413:0.009927:0.011459:0.005090:0.010820:0.006620:0.011299:0.009039:0.007807:0.005090:0.017280:0.011071:0.006551:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.004109
exist. The mutated protein is specifically targeted with BRAF inhibitors, improving the :@0.147059:0.356458:0.886507:0.356458:0.886507:0.336085:0.147059:0.336085:0.009108:0.010089:0.005615:0.007510:0.006437:0.004497:0.005376:0.011470:0.011311:0.009039:0.005387:0.017280:0.011071:0.006551:0.008811:0.006209:0.009108:0.011391:0.005376:0.011071:0.007442:0.010820:0.006209:0.009039:0.005615:0.011756:0.005387:0.005615:0.007670:0.005376:0.007510:0.011505:0.009108:0.008994:0.005615:0.005684:0.005615:0.009108:0.009405:0.005387:0.005182:0.009724:0.005376:0.006551:0.009085:0.007624:0.009656:0.009131:0.006209:0.009108:0.011391:0.005387:0.014723:0.005271:0.006620:0.011459:0.005387:0.012463:0.013650:0.014929:0.011276:0.005376:0.005615:0.011870:0.011459:0.005547:0.010820:0.005273:0.006209:0.010843:0.007624:0.007670:0.004497:0.005376:0.005615:0.017280:0.011071:0.007442:0.010866:0.009838:0.005615:0.011459:0.009861:0.005387:0.006620:0.011299:0.009039:0.004109
survival rates of patients with tumors carrying this specific alteration . This example :@0.147059:0.375861:0.886463:0.375861:0.886463:0.355488:0.147059:0.355488:0.007510:0.011413:0.008400:0.009838:0.005547:0.009838:0.009405:0.005250:0.006848:0.007898:0.008811:0.006209:0.009039:0.007670:0.006848:0.010843:0.006209:0.006848:0.011368:0.008811:0.006437:0.005547:0.009039:0.011391:0.006437:0.007670:0.006848:0.014723:0.005273:0.006620:0.011459:0.006848:0.006163:0.011413:0.017485:0.010843:0.007624:0.007670:0.006848:0.009108:0.009085:0.007807:0.008398:0.009724:0.005615:0.011459:0.009861:0.006848:0.006620:0.011459:0.005615:0.007670:0.006848:0.007510:0.011505:0.009108:0.008994:0.005615:0.005684:0.005613:0.008994:0.006848:0.009405:0.004908:0.006209:0.009039:0.007898:0.008811:0.006437:0.005545:0.010845:0.011756:0.012150:0.004497:0.006848:0.011470:0.011470:0.005615:0.007670:0.006848:0.009106:0.010089:0.009085:0.017280:0.011162:0.005182:0.009039:0.004109
23:@0.744829:0.368245:0.756992:0.368245:0.756992:0.356368:0.744829:0.356368:0.006082:0.006082
illustrates the importance of the identification of these driver mutations and genes for the :@0.147059:0.395264:0.886510:0.395264:0.886510:0.374891:0.147059:0.374891:0.005752:0.005387:0.004908:0.011413:0.007510:0.006437:0.007898:0.008811:0.006209:0.009039:0.007670:0.003310:0.006620:0.011299:0.009039:0.003310:0.005615:0.017280:0.011502:0.010845:0.007964:0.006551:0.009085:0.011598:0.008994:0.009039:0.003310:0.010843:0.006209:0.003310:0.006620:0.011299:0.009039:0.003310:0.005547:0.011322:0.009039:0.011391:0.006437:0.005615:0.005684:0.005615:0.009108:0.008811:0.006437:0.005547:0.010843:0.011756:0.003310:0.010843:0.006209:0.003310:0.006622:0.011299:0.009039:0.007873:0.009039:0.003310:0.011391:0.007807:0.005547:0.009633:0.009039:0.007807:0.003310:0.017280:0.011071:0.006551:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.003310:0.009085:0.011596:0.011391:0.003310:0.009656:0.009039:0.011596:0.009039:0.007670:0.003310:0.006026:0.010843:0.007807:0.003310:0.006620:0.011299:0.009039:0.004109
treatment and prognosis of cancer, and can only be done through genomic technologies.:@0.147059:0.414667:0.882243:0.414667:0.882243:0.394294:0.147059:0.394294:0.006437:0.007442:0.009291:0.008811:0.006437:0.017485:0.009039:0.011391:0.006437:0.003812:0.009085:0.011596:0.011391:0.003812:0.011071:0.007442:0.011048:0.009861:0.011596:0.010957:0.007601:0.005615:0.007670:0.003812:0.010843:0.006209:0.003812:0.009108:0.009085:0.011596:0.008994:0.009039:0.006255:0.004497:0.003812:0.009085:0.011598:0.011391:0.003812:0.009108:0.009085:0.011756:0.003812:0.010843:0.011870:0.005182:0.009724:0.003812:0.011254:0.009039:0.003812:0.011322:0.010843:0.011596:0.009039:0.003812:0.006620:0.011459:0.007442:0.010820:0.011413:0.009930:0.011459:0.003812:0.009656:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.003812:0.006209:0.009108:0.008765:0.011459:0.011596:0.010934:0.005182:0.011048:0.009861:0.005547:0.009039:0.007670:0.004497
During the mid-2000s affordable high-throughput sequencing became available :@0.147059:0.453472:0.886441:0.453472:0.886441:0.433099:0.147059:0.433099:0.016230:0.011413:0.007807:0.005615:0.011459:0.009861:0.013171:0.006620:0.011299:0.009039:0.013171:0.017645:0.005547:0.011391:0.007533:0.010432:0.010432:0.010432:0.010432:0.007670:0.013171:0.009085:0.005969:0.005787:0.010843:0.007442:0.011573:0.009108:0.010911:0.005182:0.009039:0.013171:0.011459:0.005615:0.009930:0.011459:0.007533:0.006620:0.011459:0.007442:0.010820:0.011413:0.009930:0.011094:0.011048:0.011071:0.006437:0.013171:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.013171:0.011254:0.009108:0.009108:0.009085:0.017485:0.009039:0.013171:0.008925:0.009838:0.009085:0.005752:0.005433:0.009108:0.010911:0.005182:0.009039:0.004109
through platforms like 454 , SOLiD from Thermo Fisher , Solexa  and several :@0.147059:0.472875:0.886475:0.472875:0.886475:0.452502:0.147059:0.452502:0.006620:0.011459:0.007442:0.010820:0.011413:0.009930:0.011459:0.010888:0.011162:0.005433:0.008811:0.006437:0.006026:0.010843:0.007807:0.017508:0.007670:0.010888:0.005250:0.005752:0.010272:0.009039:0.010888:0.010432:0.010432:0.010432:0.012138:0.004497:0.010888:0.010112:0.016050:0.011731:0.005615:0.016139:0.010888:0.006414:0.007442:0.010843:0.017645:0.010888:0.011470:0.011311:0.009039:0.007807:0.017485:0.011048:0.010888:0.011391:0.005615:0.007553:0.011302:0.009039:0.007807:0.012130:0.004497:0.010888:0.010592:0.010934:0.005182:0.009108:0.010089:0.009291:0.012155:0.010888:0.009085:0.011596:0.011391:0.010888:0.007873:0.009336:0.009633:0.009039:0.007898:0.009405:0.005250:0.004109
24:@0.392148:0.465259:0.404311:0.465259:0.404311:0.453382:0.392148:0.453382:0.006082:0.006082
25:@0.675186:0.465259:0.687349:0.465259:0.687349:0.453382:0.675186:0.453382:0.006082:0.006082
26:@0.757920:0.465259:0.770084:0.465259:0.770084:0.453382:0.757920:0.453382:0.006082:0.006082
others, encompassed under the umbrella term next-generation sequencing (NGS). :@0.147059:0.492278:0.886484:0.492278:0.886484:0.471905:0.147059:0.471905:0.010820:0.006620:0.011299:0.009039:0.007624:0.007670:0.004497:0.009679:0.009039:0.011596:0.008994:0.010843:0.017280:0.011368:0.009291:0.007533:0.007875:0.009106:0.011391:0.009679:0.011413:0.011596:0.011322:0.009039:0.007807:0.009679:0.006620:0.011299:0.009039:0.009679:0.011413:0.017394:0.010820:0.007442:0.008948:0.005387:0.005433:0.009291:0.009679:0.006209:0.009039:0.007807:0.017645:0.009679:0.011596:0.009108:0.010089:0.006437:0.007533:0.009656:0.009039:0.011596:0.009039:0.007898:0.008811:0.006437:0.005547:0.010843:0.011756:0.009679:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.009679:0.006939:0.015887:0.015682:0.010112:0.006939:0.004497:0.004109
Since then, throughput and price of these technologies has steadily improved, with the :@0.147059:0.511681:0.886555:0.511681:0.886555:0.491308:0.147059:0.491308:0.010112:0.005615:0.011596:0.008994:0.009039:0.005273:0.006620:0.011299:0.009039:0.011756:0.004497:0.005273:0.006620:0.011459:0.007442:0.010818:0.011413:0.009930:0.011094:0.011048:0.011071:0.006437:0.005273:0.009085:0.011598:0.011391:0.005262:0.011071:0.007807:0.005547:0.008994:0.009039:0.005273:0.010843:0.006209:0.005273:0.006620:0.011299:0.009039:0.007875:0.009039:0.005273:0.006209:0.009108:0.008765:0.011459:0.011596:0.010934:0.005182:0.011048:0.009861:0.005547:0.009039:0.007670:0.005273:0.011391:0.009291:0.007670:0.005273:0.007510:0.006209:0.009288:0.009291:0.011391:0.005752:0.005182:0.009724:0.005273:0.005615:0.017280:0.011071:0.007442:0.010866:0.009633:0.009108:0.011117:0.004497:0.005273:0.014723:0.005273:0.006620:0.011459:0.005262:0.006620:0.011302:0.009039:0.004109
biotechnological company Illumina (after acquiring Solexa) as market leader. Thus, :@0.147059:0.531083:0.886484:0.531083:0.886484:0.510710:0.147059:0.510710:0.010820:0.005547:0.010820:0.006209:0.009108:0.008765:0.011459:0.011596:0.010934:0.005182:0.011048:0.009861:0.005547:0.009108:0.009405:0.005250:0.008537:0.008994:0.010840:0.017282:0.011365:0.009085:0.011370:0.009724:0.008537:0.007190:0.005387:0.004908:0.011413:0.017645:0.005615:0.011687:0.009291:0.008537:0.006939:0.009085:0.006197:0.005969:0.009039:0.007807:0.008537:0.009291:0.008994:0.010706:0.011413:0.005615:0.007807:0.005615:0.011459:0.009861:0.008537:0.010589:0.010936:0.005182:0.009106:0.010089:0.009291:0.006939:0.008537:0.009291:0.007670:0.008537:0.017577:0.009085:0.007601:0.010272:0.009131:0.006437:0.008537:0.005182:0.009291:0.009291:0.011322:0.009039:0.006255:0.004497:0.008537:0.011470:0.011105:0.011413:0.007670:0.004497:0.004109
assays like whole-exome sequencing (WES), where the protein-coding part of the :@0.147059:0.550486:0.886395:0.550486:0.886395:0.530113:0.147059:0.530113:0.009291:0.007533:0.007944:0.008925:0.009724:0.007670:0.009610:0.005250:0.005752:0.010272:0.009039:0.009610:0.014792:0.011299:0.010934:0.005182:0.009039:0.007533:0.009108:0.009884:0.010843:0.017485:0.009039:0.009610:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.009610:0.006825:0.021001:0.012098:0.010112:0.006939:0.004497:0.009610:0.014792:0.011299:0.009039:0.007442:0.009039:0.009610:0.006617:0.011302:0.009039:0.009610:0.011071:0.007442:0.010820:0.006209:0.009039:0.005615:0.011756:0.007533:0.008994:0.011276:0.011391:0.005615:0.011459:0.009861:0.009610:0.011368:0.009085:0.007967:0.006437:0.009610:0.010843:0.006209:0.009610:0.006620:0.011299:0.009039:0.004109
genome is sequenced, and whole-genome sequencing (WGS) have become increasingly :@0.147059:0.569889:0.886535:0.569889:0.886535:0.549516:0.147059:0.549516:0.009656:0.009039:0.011596:0.010843:0.017485:0.009039:0.004406:0.005615:0.007670:0.004406:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.009108:0.011117:0.004497:0.004406:0.009085:0.011596:0.011391:0.004406:0.014792:0.011299:0.010934:0.005182:0.009039:0.007533:0.009656:0.009039:0.011596:0.010843:0.017488:0.009039:0.004406:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.004406:0.006825:0.020270:0.015682:0.010112:0.006939:0.004406:0.011391:0.008925:0.009633:0.009039:0.004406:0.011251:0.009108:0.008994:0.010845:0.017485:0.009039:0.004406:0.005615:0.011596:0.008994:0.007442:0.009291:0.009291:0.007601:0.005615:0.011459:0.009930:0.005182:0.009724:0.004109
important in cancer research. Among countless techniques, knowledge and milestones :@0.147059:0.589292:0.886395:0.589292:0.886395:0.568919:0.147059:0.568919:0.005615:0.017280:0.011505:0.010843:0.007967:0.006551:0.009085:0.011391:0.006437:0.005159:0.005615:0.011756:0.005159:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.005159:0.007442:0.009039:0.007875:0.009291:0.009085:0.007442:0.008765:0.011459:0.004497:0.005159:0.014929:0.017485:0.010843:0.011459:0.009861:0.005159:0.008994:0.010820:0.011413:0.011391:0.006620:0.005182:0.009039:0.007533:0.007670:0.005159:0.006209:0.009108:0.008765:0.011459:0.011756:0.005547:0.010706:0.011345:0.009039:0.007670:0.004497:0.005159:0.010706:0.011596:0.010866:0.014792:0.005182:0.009108:0.011391:0.009656:0.009039:0.005159:0.009085:0.011596:0.011391:0.005159:0.017645:0.005752:0.005182:0.009039:0.007510:0.006209:0.010843:0.011596:0.009039:0.007670:0.004109
unlocked by NGS are the development of large international cancer sequencing consortia :@0.147059:0.608695:0.886535:0.608695:0.886535:0.588322:0.147059:0.588322:0.011413:0.011870:0.005182:0.011276:0.008765:0.010272:0.009108:0.011391:0.002922:0.010843:0.009724:0.002922:0.015887:0.015682:0.010112:0.002922:0.009085:0.007444:0.009039:0.002922:0.006620:0.011299:0.009039:0.002922:0.011322:0.009336:0.009633:0.008948:0.005182:0.010820:0.011071:0.017485:0.009039:0.011391:0.006437:0.002922:0.010843:0.006209:0.002922:0.005430:0.009087:0.007624:0.009656:0.009039:0.002922:0.005615:0.011391:0.006209:0.009039:0.007807:0.011687:0.008811:0.006437:0.005547:0.010843:0.011687:0.009405:0.005250:0.002922:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.002922:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.002922:0.008994:0.010845:0.011619:0.007873:0.010843:0.007967:0.006437:0.005798:0.009291:0.004109
such as ICGC , TCGA , PCAWG , HMF  or several focused on pediatric cancer:@0.147059:0.628097:0.846650:0.628097:0.846650:0.607724:0.147059:0.607724:0.007510:0.011345:0.008765:0.011459:0.004622:0.009291:0.007670:0.004634:0.006825:0.014744:0.015682:0.014678:0.012154:0.004497:0.004622:0.013057:0.014746:0.015682:0.014929:0.012163:0.004497:0.004622:0.012167:0.014678:0.012783:0.020270:0.015682:0.012163:0.004497:0.004622:0.016846:0.019608:0.011276:0.012163:0.004622:0.010843:0.007807:0.004622:0.007875:0.009336:0.009633:0.009039:0.007898:0.009405:0.005250:0.004622:0.006026:0.011276:0.009108:0.011413:0.007875:0.009108:0.011391:0.004622:0.010843:0.011756:0.004622:0.011505:0.009108:0.011391:0.005798:0.008811:0.006437:0.007807:0.005547:0.008994:0.004622:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807
27:@0.264275:0.620481:0.276438:0.620481:0.276438:0.608604:0.264275:0.608604:0.006082:0.006082
28:@0.343971:0.620481:0.356134:0.620481:0.356134:0.608604:0.343971:0.608604:0.006082:0.006082
19:@0.440832:0.620481:0.452996:0.620481:0.452996:0.608604:0.440832:0.608604:0.006082:0.006082
29:@0.509845:0.620481:0.522009:0.620481:0.522009:0.608604:0.509845:0.608604:0.006082:0.006082
30–32:@0.846649:0.620481:0.877857:0.620481:0.877857:0.608604:0.846649:0.608604:0.006082:0.006082:0.006880:0.006082:0.006082
. :@0.877856:0.628097:0.886461:0.628097:0.886461:0.607724:0.877856:0.607724:0.004497:0.004109
Through sequencing of these large cohorts our knowledge about the origin, behavior, :@0.147059:0.647500:0.886484:0.647500:0.886484:0.627127:0.147059:0.627127:0.011470:0.011470:0.007442:0.010820:0.011413:0.009930:0.011459:0.006209:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.006209:0.010843:0.006209:0.006209:0.006620:0.011299:0.009039:0.007875:0.009039:0.006209:0.005433:0.009085:0.007624:0.009656:0.009039:0.006209:0.008994:0.010934:0.011299:0.010843:0.007967:0.006437:0.007670:0.006209:0.010822:0.011413:0.007807:0.006209:0.010706:0.011596:0.010866:0.014789:0.005182:0.009108:0.011391:0.009656:0.009039:0.006209:0.009106:0.011254:0.010820:0.011071:0.006437:0.006209:0.006620:0.011302:0.009039:0.006209:0.010843:0.007807:0.005615:0.009861:0.005615:0.011756:0.004497:0.006209:0.011251:0.008948:0.011391:0.008925:0.009838:0.005547:0.010843:0.006255:0.004497:0.004109
evolution and actionability of tumors has greatly improved in the last decade. Although :@0.147059:0.666903:0.886503:0.666903:0.886503:0.646530:0.147059:0.646530:0.009336:0.009633:0.010934:0.004908:0.011071:0.006437:0.005547:0.010843:0.011756:0.004474:0.009085:0.011596:0.011391:0.004474:0.009291:0.009108:0.006437:0.005547:0.010840:0.011690:0.009108:0.010820:0.005750:0.005250:0.005273:0.006437:0.009724:0.004474:0.010840:0.006209:0.004474:0.006163:0.011413:0.017485:0.010843:0.007624:0.007670:0.004474:0.011391:0.009291:0.007670:0.004474:0.009861:0.007439:0.009291:0.008811:0.006620:0.005182:0.009724:0.004474:0.005615:0.017280:0.011071:0.007442:0.010866:0.009633:0.009108:0.011391:0.004474:0.005615:0.011756:0.004474:0.006620:0.011299:0.009039:0.004474:0.005433:0.009291:0.007510:0.006437:0.004474:0.011322:0.009108:0.009108:0.009291:0.011322:0.008743:0.004497:0.004474:0.015066:0.004908:0.006620:0.011299:0.010820:0.011413:0.009930:0.011459:0.004109
genomic data are already being used to guide treatment decisions in a variety of cancers, :@0.147059:0.686306:0.886329:0.686306:0.886329:0.665933:0.147059:0.665933:0.009656:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.004063:0.011573:0.008811:0.006551:0.009291:0.004063:0.009087:0.007442:0.009039:0.004063:0.009405:0.005250:0.007442:0.009291:0.009291:0.011322:0.009724:0.004063:0.011254:0.009039:0.005615:0.011459:0.009861:0.004063:0.011413:0.007875:0.009108:0.011391:0.004063:0.006209:0.011048:0.004063:0.009861:0.011413:0.005547:0.011322:0.009039:0.004063:0.006437:0.007442:0.009291:0.008811:0.006437:0.017485:0.009039:0.011391:0.006437:0.004063:0.011322:0.009106:0.008994:0.005615:0.007601:0.005547:0.010843:0.011619:0.007670:0.004063:0.005615:0.011756:0.004063:0.009291:0.004063:0.009838:0.009085:0.007807:0.005547:0.009131:0.006437:0.009724:0.004063:0.010845:0.006209:0.004063:0.009108:0.009085:0.011596:0.008994:0.009039:0.007624:0.007670:0.004497:0.004109
this is mainly done through targeted gene panels as WES and WGS are less used in :@0.147059:0.705708:0.886441:0.705708:0.886441:0.685335:0.147059:0.685335:0.006620:0.011459:0.005615:0.007670:0.007145:0.005615:0.007670:0.007145:0.017577:0.009085:0.005615:0.011870:0.005182:0.009724:0.007145:0.011322:0.010843:0.011596:0.009039:0.007145:0.006620:0.011459:0.007442:0.010820:0.011413:0.009927:0.011459:0.007145:0.006551:0.009085:0.007624:0.009656:0.009131:0.006209:0.009108:0.011391:0.007145:0.009658:0.009039:0.011596:0.009039:0.007145:0.011368:0.009085:0.011596:0.008948:0.005250:0.007670:0.007145:0.009291:0.007670:0.007145:0.021001:0.012098:0.010112:0.007145:0.009085:0.011596:0.011391:0.007145:0.020270:0.015682:0.010112:0.007145:0.009085:0.007442:0.009039:0.007145:0.005182:0.009039:0.007533:0.007670:0.007145:0.011413:0.007875:0.009108:0.011391:0.007145:0.005615:0.011756:0.004109
clinical care than in research, mainly due to limitations in the availability of fresh-frozen :@0.147059:0.725111:0.886416:0.725111:0.886416:0.704738:0.147059:0.704738:0.008765:0.005250:0.005615:0.011756:0.005547:0.009108:0.009405:0.005250:0.004086:0.009108:0.009085:0.007442:0.009039:0.004086:0.006620:0.011391:0.009085:0.011756:0.004086:0.005615:0.011756:0.004086:0.007442:0.009039:0.007875:0.009291:0.009085:0.007442:0.008765:0.011459:0.004497:0.004086:0.017577:0.009085:0.005615:0.011870:0.005182:0.009724:0.004086:0.011048:0.011345:0.009039:0.004086:0.006209:0.011048:0.004086:0.005250:0.005615:0.017645:0.005273:0.006549:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.004086:0.005615:0.011756:0.004086:0.006620:0.011299:0.009039:0.004086:0.008925:0.009838:0.009087:0.005752:0.005430:0.009108:0.010820:0.005752:0.005250:0.005273:0.006437:0.009724:0.004086:0.010843:0.006209:0.004086:0.006414:0.007442:0.009039:0.007556:0.011459:0.007533:0.006414:0.007442:0.010934:0.008834:0.009039:0.011756:0.004109
tissue from the tumor biopsies in clinical practice and higher costs when compared to :@0.147059:0.744514:0.886487:0.744514:0.886487:0.724141:0.147059:0.724141:0.006437:0.005615:0.007533:0.007510:0.011345:0.009039:0.005593:0.006414:0.007442:0.010843:0.017645:0.005593:0.006620:0.011299:0.009039:0.005593:0.006163:0.011413:0.017485:0.010843:0.007807:0.005593:0.010820:0.005547:0.010820:0.011185:0.007601:0.005547:0.009039:0.007670:0.005593:0.005615:0.011756:0.005593:0.008765:0.005250:0.005615:0.011756:0.005547:0.009108:0.009405:0.005250:0.005593:0.011071:0.007898:0.009291:0.009108:0.006437:0.005547:0.008994:0.009039:0.005593:0.009085:0.011596:0.011391:0.005593:0.011459:0.005615:0.009930:0.011299:0.009039:0.007807:0.005593:0.008994:0.010957:0.007510:0.006437:0.007670:0.005593:0.014792:0.011299:0.009039:0.011756:0.005593:0.008994:0.010845:0.017278:0.011368:0.009085:0.007442:0.009108:0.011391:0.005593:0.006209:0.011048:0.004109
standard diagnostic techniques:@0.147059:0.763917:0.411142:0.763917:0.411142:0.743544:0.147059:0.743544:0.007510:0.006551:0.009085:0.011596:0.011573:0.009085:0.007442:0.011391:0.005478:0.011391:0.005798:0.009199:0.009861:0.011596:0.010957:0.007510:0.006437:0.005547:0.008994:0.005478:0.006209:0.009108:0.008765:0.011459:0.011756:0.005547:0.010706:0.011345:0.009039:0.007670
33–35:@0.411155:0.756301:0.442362:0.756301:0.442362:0.744423:0.411155:0.744423:0.006082:0.006082:0.006880:0.006082:0.006082
. Nevertheless, WGS is the only technique that fully :@0.442361:0.763917:0.886408:0.763917:0.886408:0.743544:0.442361:0.743544:0.004497:0.005478:0.015522:0.009336:0.009633:0.009039:0.007967:0.006620:0.011299:0.008948:0.005182:0.009039:0.007533:0.007670:0.004497:0.005478:0.020270:0.015682:0.010112:0.005478:0.005615:0.007670:0.005478:0.006620:0.011299:0.009039:0.005478:0.010843:0.011870:0.005182:0.009724:0.005478:0.006209:0.009108:0.008765:0.011459:0.011756:0.005547:0.010706:0.011345:0.009039:0.005478:0.006620:0.011391:0.008811:0.006437:0.005478:0.006369:0.011550:0.005385:0.005182:0.009724:0.004109
characterizes the genomic complexity and heterogeneity of a tumor. For this reason, :@0.147059:0.783319:0.886491:0.783319:0.886491:0.762947:0.147059:0.762947:0.008765:0.011391:0.009085:0.007898:0.009291:0.009108:0.006209:0.009039:0.007807:0.005615:0.008834:0.009039:0.007670:0.007225:0.006620:0.011299:0.009039:0.007236:0.009656:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.007225:0.008994:0.010843:0.017280:0.011162:0.005182:0.009108:0.010089:0.005273:0.006437:0.009724:0.007225:0.009087:0.011596:0.011391:0.007225:0.011299:0.009131:0.006209:0.009039:0.007442:0.011048:0.009656:0.009039:0.011596:0.009039:0.005273:0.006437:0.009724:0.007236:0.010843:0.006209:0.007225:0.009291:0.007225:0.006166:0.011413:0.017485:0.010843:0.006255:0.004497:0.007225:0.010683:0.010843:0.007807:0.007236:0.006620:0.011459:0.005615:0.007670:0.007225:0.007442:0.009291:0.009291:0.007875:0.010843:0.011756:0.004497:0.004109
together with technical improvements to reduce costs, there is little doubt that WGS :@0.147059:0.802722:0.886395:0.802722:0.886395:0.782349:0.147059:0.782349:0.006209:0.011048:0.009656:0.009131:0.006620:0.011299:0.009039:0.007807:0.006848:0.014723:0.005273:0.006620:0.011459:0.006848:0.006209:0.009108:0.008765:0.011459:0.011756:0.005547:0.009108:0.009402:0.005250:0.006848:0.005615:0.017280:0.011071:0.007442:0.010866:0.009633:0.009039:0.017485:0.009039:0.011391:0.006437:0.007670:0.006848:0.006211:0.011048:0.006848:0.007442:0.009108:0.011048:0.011345:0.008994:0.009039:0.006848:0.008994:0.010955:0.007512:0.006437:0.007670:0.004497:0.006848:0.006620:0.011299:0.009039:0.007442:0.009039:0.006848:0.005615:0.007670:0.006848:0.005250:0.005273:0.006163:0.006620:0.005182:0.009039:0.006848:0.011322:0.010820:0.011345:0.010797:0.006437:0.006848:0.006620:0.011391:0.008811:0.006437:0.006848:0.020270:0.015682:0.010112:0.004109
will eventually be implemented routinely in cancer precision medicine . An additional :@0.147059:0.822125:0.886452:0.822125:0.886452:0.801752:0.147059:0.801752:0.014723:0.005752:0.005387:0.005250:0.004771:0.009336:0.009633:0.009039:0.011391:0.006163:0.011596:0.009405:0.005387:0.005182:0.009724:0.004771:0.011254:0.009039:0.004771:0.005615:0.017280:0.011162:0.005182:0.009039:0.017485:0.009039:0.011391:0.006209:0.009108:0.011391:0.004771:0.007442:0.010820:0.011071:0.006437:0.005615:0.011596:0.008948:0.005182:0.009724:0.004771:0.005615:0.011756:0.004771:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.004771:0.011071:0.007442:0.009108:0.008994:0.005615:0.007601:0.005547:0.010843:0.011756:0.004771:0.017485:0.009108:0.011391:0.005547:0.008994:0.005615:0.011596:0.009039:0.012201:0.004497:0.004771:0.014929:0.011756:0.004771:0.009291:0.011322:0.011391:0.005273:0.006437:0.005547:0.010843:0.011687:0.009405:0.005250:0.004109
36:@0.743012:0.814509:0.755176:0.814509:0.755176:0.802632:0.743012:0.802632:0.006082:0.006082
advantage of clinical implementation of WGS is the replacement of many standalone :@0.147059:0.841528:0.886375:0.841528:0.886375:0.821155:0.147059:0.821155:0.009291:0.011322:0.009838:0.009085:0.011391:0.006551:0.009199:0.009656:0.009039:0.006414:0.010843:0.006209:0.006414:0.008765:0.005250:0.005615:0.011756:0.005547:0.009108:0.009405:0.005250:0.006414:0.005615:0.017280:0.011162:0.005182:0.009039:0.017485:0.009039:0.011391:0.006551:0.008811:0.006437:0.005547:0.010843:0.011756:0.006414:0.010843:0.006209:0.006414:0.020270:0.015682:0.010112:0.006414:0.005615:0.007670:0.006414:0.006620:0.011302:0.009039:0.006414:0.007442:0.009131:0.011162:0.005433:0.009291:0.008994:0.009039:0.017485:0.009039:0.011391:0.006437:0.006414:0.010843:0.006209:0.006414:0.017577:0.009085:0.011368:0.009724:0.006414:0.007510:0.006551:0.009085:0.011596:0.011573:0.009405:0.005182:0.010843:0.011596:0.009039:0.004109
tests for different cancer types or mutation types, bringing in a single test for all cancers :@0.147059:0.860931:0.886532:0.860931:0.886532:0.840558:0.147059:0.840558:0.006209:0.009039:0.007510:0.006437:0.007670:0.004725:0.006026:0.010843:0.007807:0.004725:0.011391:0.005615:0.005969:0.005787:0.009039:0.007442:0.009039:0.011391:0.006437:0.004725:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.004725:0.006437:0.009724:0.011505:0.009039:0.007670:0.004725:0.010843:0.007807:0.004725:0.017280:0.011071:0.006551:0.008811:0.006437:0.005547:0.010843:0.011756:0.004725:0.006437:0.009724:0.011505:0.009039:0.007670:0.004497:0.004725:0.010820:0.007807:0.005615:0.011459:0.009861:0.005615:0.011459:0.009861:0.004725:0.005615:0.011756:0.004725:0.009291:0.004725:0.007601:0.005615:0.011459:0.009930:0.005182:0.009039:0.004725:0.006209:0.009039:0.007510:0.006437:0.004725:0.006026:0.010843:0.007807:0.004725:0.009405:0.005387:0.005250:0.004725:0.009108:0.009085:0.011596:0.008994:0.009039:0.007624:0.007670:0.004109
and harmonizing protocols for sample collections and data analysis .:@0.147059:0.880334:0.727538:0.880334:0.727538:0.859961:0.147059:0.859961:0.009085:0.011596:0.011391:0.004109:0.011391:0.009085:0.007807:0.017485:0.010843:0.011756:0.005615:0.008834:0.005615:0.011459:0.009861:0.004109:0.011071:0.007442:0.010820:0.006209:0.011276:0.008994:0.010934:0.005250:0.007670:0.004109:0.006026:0.010843:0.007807:0.004109:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.004109:0.008994:0.010934:0.005387:0.005182:0.009108:0.009106:0.006437:0.005547:0.010843:0.011619:0.007670:0.004109:0.009085:0.011598:0.011391:0.004109:0.011571:0.008811:0.006551:0.009291:0.004109:0.009085:0.011687:0.009405:0.005182:0.009724:0.007601:0.005615:0.007670:0.012163:0.004497
36:@0.710878:0.872717:0.723042:0.872717:0.723042:0.860840:0.710878:0.860840:0.006082:0.006082